Project File Details


Download the complete microbiology project topic and material (chapter 1-5) titled TREATMENT OF CANDIDIASIS USING CONVENTIONAL ANTIFUNGAL DRUGS here on PROJECTS.ng. See below for the abstract, table of contents, list of figures, list of tables, list of appendices, list of abbreviations and chapter one. Click the DOWNLOAD NOW button to get the complete project work instantly.

 

3,000.00

Download the complete microbiology project topic and material (chapter 1-5) titled TREATMENT OF CANDIDIASIS USING CONVENTIONAL ANTIFUNGAL DRUGS here on PROJECTS.ng. See below for the abstract, table of contents, list of figures, list of tables, list of appendices, list of abbreviations and chapter one. Click the DOWNLOAD NOW button to get the complete project work instantly.

 

PROJECT TOPIC AND MATERIAL ON TREATMENT OF CANDIDIASIS USING CONVENTIONAL ANTIFUNGAL DRUGS

The Project File Details

  • Name: TREATMENT OF CANDIDIASIS USING CONVENTIONAL ANTIFUNGAL DRUGS
  • Type: PDF and MS Word (DOC)
  • Size: [86 KB]
  • Length: [21] Pages

 

ABSTRACT

Candidiasis is an opportunistic mycoses caused by the yeast genus Candida. The genus comprises of many species of which Candidaalbicansis the most common. Candidiasis can cause a wide spectrum of clinical syndromes which include cutaneous candidiasis, gastrointestinal tract candidiasis, respiratory tract candidiasis, genitourinary tract candidiasis, hepatosplenic candidiasis and systemic candidiasis. Conventional antifungal drugs are drugs widely accepted for the treatment of fungal infections. Conventional antifungal drugs used in the treatment of candidiasis belong to three (3) principal classes: the Echinocandins (caspofungin, anidulafungin and micafungin) used for the treatment of systemic candidiasis, the Azoles (fluconazole, voriconazole, posaconazole) and the Polyenes (amphotericin B) for the treatment of cutaneous and chronic mucocutaneous candidiasis. The treatments of these Candida infections with the conventional antifungal drugs vary substantially and are based on the anatomic location of the infection, the patients’ underlying disease and immune status, the patients’ risk factors for infection, and the specific species of Candida responsible for infection, though these speciesare either susceptible or resistant to the drugs, for instance, Candida krusei is susceptible to voriconazole but resistant to fluconazole. Conventional antifungal drugs are an essential key towards the treatment of candidiasis, but require monitoring and modification to ensure adequate treatment of the disease.

CHAPTER ONE

INTRODUCTION

Candidiasis is an opportunistic mycoses. It is a fungal infection caused by the yeast genus Candida.Several species of the yeast Candida are capable of causing candidiasis (Brookset al., 2013). Thegenusis composedof organisms such as Candidaalbicans(common cause of candidiasis), Candidaglabrata, Candidaparapsilosis,Candida balanitis, Candida guilliermondii,andCandidakrusei (Pfalleretal.,2007). Candidaspecies belong to the normalmicrobiotaofanindividual’s mucosal oralcavity, gastrointestinal tract andvagina (Shaoetal.,2007),andare manifested by mucocutaneous lesions, fungemia, and sometimes focal infection of multiple sites.Symptoms depend on the site of infection and include dysphagia, skin and mucosal lesions, blindness, vaginal symptoms (itching, burning, discharge), fever, shock, oliguria, renal shutdown, and disseminated intravascular coagulation. Diagnosis is done by histopathology and cultures from normally sterile sites.

Conventional antifungal drugs are drugs widely accepted to fight fungal organisms causing infection and diseases in humans. In the United States, only ten (10) antifungal drugs are currently approved by the Food and Drug Administration (FDA) for the therapy of systemic fungal infections (William, 2000). Conventional antifungal drugs used in the treatment of candidiasis belongto three (3) principal classes: polyenes (amphotericin B), echinocandins(caspofungin, anidulafungin and micafungin) and azoles (fluconazole, voriconazole, posaconazole).Candida species are susceptible, less susceptible or resistant to these antifungal drugs. For instance, some C. glabrataisolates are resistant to fluconazole and allC. krusei isolates are resistant to fluconazole.

The purpose of this presentation is to educate on the widely accepted antifungal drugs for the treatment of candididiasis in different locations of the human body, the Candida species’ susceptibility and resistance to the drugs, and administration of the drugs.

CANDIDIASIS

Candidiasis is an opportunistic infection. It’s a yeast infection caused by Candida species (most often C. albicans), C. kruseiCandidaglabrata, Candidaparapsilosis, Candida balanitis, Candida guilliermondii, andCandidatropicalis, Candida cystitis, Candida kefyr, and Candida lusitaniae. Candida species are commensal organisms that inhabit the gastrointestinal tract and sometimes the skin. Candidiasis results from endogenous organisms unlike other systemic mycoses. Candidal infections are one of the most common hospital-acquired infections. It occurs both in men, female and children. It can be transmitted through various means such as oral sex, sex, breast feeding etc. Symptoms depend on the site of infection and include dysphagia, skin and mucosal lesions, blindness, vaginal symptoms (itching, burning, discharge), fever, shock, oliguria, renal shutdown, and disseminated intravascular coagulation. Diagnosis is confirmed by histopathology and cultures from normally sterile sites.

CONVENTIONAL ANTIFUNGAL DRUGS

Conventional antifungal drugs are drugs widely or generally accepted for the treatment of fungal infections and diseases. In the United States, only ten (10) antifungal drugs are currently approved by the Food and Drug Administration (FDA) for the therapy of systemic fungal infections (William, 2000). These drugs belong to four principal classes: polyenes, pyrimidines, azoles and echinocandins.

 

See more microbiology project topics and materials

GET THE FULL WORK

DISCLAIMER:
All project works, files and documents posted on this website, projects.ng are the property/copyright of their respective owners. They are for research reference/guidance purposes only and the works are crowd-sourced. Please don’t submit someone’s work as your own to avoid plagiarism and its consequences. Use it as a guidance purpose only and not copy the work word for word (verbatim). Projects.ng is a repository of research works just like academia.edu, researchgate.net, scribd.com, docsity.com, coursehero and many other platforms where users upload works. The paid subscription on projects.ng is a means by which the website is maintained to support Open Education. If you see your work posted here, and you want it to be removed/credited, please call us on +2348159154070 or send us a mail together with the web address link to the work, to [email protected] We will reply to and honor every request. Please notice it may take up to 24 - 48 hours to process your request.